Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 1
1995 1
1997 1
1998 1
1999 1
2000 1
2002 1
2007 2
2008 2
2009 3
2010 4
2011 4
2012 1
2013 6
2014 2
2015 5
2016 5
2017 2
2018 3
2019 2
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial.
Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB, Botros FT. Tuttle KR, et al. Among authors: zimmermann ag. Lancet Diabetes Endocrinol. 2018 Aug;6(8):605-617. doi: 10.1016/S2213-8587(18)30104-9. Epub 2018 Jun 14. Lancet Diabetes Endocrinol. 2018. PMID: 29910024 Clinical Trial.
GLP-1 receptor agonists, CKD, and eGFR trajectory - Authors' reply.
Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB, Botros FT. Tuttle KR, et al. Among authors: zimmermann ag. Lancet Diabetes Endocrinol. 2018 Oct;6(10):765. doi: 10.1016/S2213-8587(18)30239-0. Lancet Diabetes Endocrinol. 2018. PMID: 30266182 No abstract available.
Conventional murine gene targeting.
Zimmermann AG, Sun Y. Zimmermann AG, et al. Methods Mol Biol. 2013;1031:1-18. doi: 10.1007/978-1-62703-481-4_1. Methods Mol Biol. 2013. PMID: 23824881
Survey of professionals on breast cancer, fertility preservation and pregnancy in Argentina.
García A, Candás G, Bemi A, Vuoto HD, Korbenfeld E, Isetta J, Cogorno L, Zimmermann AG, Sigal M, Acevedo S, Berwart J, Naveira M, Ocampo MD, Uriburu JL. García A, et al. Among authors: zimmermann ag. Ecancermedicalscience. 2021 Feb 10;15:1183. doi: 10.3332/ecancer.2021.1183. eCollection 2021. Ecancermedicalscience. 2021. PMID: 33777176 Free PMC article.
Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program.
Child CJ, Zimmermann AG, Chrousos GP, Cummings E, Deal CL, Hasegawa T, Jia N, Lawrence S, Linglart A, Loche S, Maghnie M, Pérez Sánchez J, Polak M, Predieri B, Richter-Unruh A, Rosenfeld RG, Yeste D, Yorifuji T, Blum WF. Child CJ, et al. Among authors: zimmermann ag. J Clin Endocrinol Metab. 2019 Feb 1;104(2):379-389. doi: 10.1210/jc.2018-01189. J Clin Endocrinol Metab. 2019. PMID: 30219920 Free PMC article.
Impact of immunohistochemical profile changes following neoadjuvant therapy in the treatment of breast cancer.
Candás G, García A, Ocampo MD, Korbenfeld E, Vuoto HD, Isetta J, Cogorno L, Zimmermann AG, Sigal M, Acevedo S, Berwart J, Naveira M, Bemi A, Uriburu JL. Candás G, et al. Among authors: zimmermann ag. Ecancermedicalscience. 2021 Jan 5;15:1162. doi: 10.3332/ecancer.2021.1162. eCollection 2021. Ecancermedicalscience. 2021. PMID: 33680076 Free PMC article.
NLRX1 is a regulator of mitochondrial antiviral immunity.
Moore CB, Bergstralh DT, Duncan JA, Lei Y, Morrison TE, Zimmermann AG, Accavitti-Loper MA, Madden VJ, Sun L, Ye Z, Lich JD, Heise MT, Chen Z, Ting JP. Moore CB, et al. Among authors: zimmermann ag. Nature. 2008 Jan 31;451(7178):573-7. doi: 10.1038/nature06501. Epub 2008 Jan 16. Nature. 2008. PMID: 18200010
46 results